Search Results

There are 5809 results for: content related to: Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy

  1. You have full text access to this OnlineOpen article
    Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 430–441, Eva Juengel, Dana Kim, Jasmina Makarević, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp and Roman A. Blaheta

    Article first published online : 2 DEC 2014, DOI: 10.1111/jcmm.12471

  2. You have full text access to this OnlineOpen article
    Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment

    Cancer Science

    Volume 106, Issue 2, February 2015, Pages: 160–170, Gökçe Hatipoglu, Stefan W. Hock, Ruth Weiss, Zheng Fan, Tina Sehm, Ali Ghoochani, Michael Buchfelder, Nicolai E. Savaskan and Ilker Y. Eyüpoglu

    Article first published online : 15 FEB 2015, DOI: 10.1111/cas.12580

  3. You have free access to this content
    PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma-cell lines

    International Journal of Cancer

    Volume 131, Issue 2, 15 July 2012, Pages: E45–E55, Claus Bender and Axel Ullrich

    Article first published online : 28 FEB 2012, DOI: 10.1002/ijc.26486

  4. You have full text access to this OnlineOpen article
    Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction

    Cancer Medicine

    Volume 4, Issue 7, July 2015, Pages: 1003–1015, Esther A. Kleibeuker, Matthijs A. ten Hooven, Kitty C. Castricum, Richard Honeywell, Arjan W. Griffioen, Henk M. Verheul, Ben J. Slotman and Victor L. Thijssen

    Article first published online : 31 MAR 2015, DOI: 10.1002/cam4.441

  5. You have free access to this content
    Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 809–819, Huixin Yu, Neeltje Steeghs, Jacqueline S. L. Kloth, Djoeke de Wit, J. G. Coen van Hasselt, Nielka P. van Erp, Jos H. Beijnen, Jan H. M. Schellens, Ron H. J. Mathijssen and Alwin D. R. Huitema

    Article first published online : 22 APR 2015, DOI: 10.1111/bcp.12550

  6. Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem-like cells

    The Prostate

    Volume 75, Issue 11, August 1, 2015, Pages: 1137–1149, Roque Diaz, Paul A. Nguewa, Miriam Redrado, Irene Manrique and Alfonso Calvo

    Article first published online : 20 APR 2015, DOI: 10.1002/pros.22980

  7. You have full text access to this Open Access content
    Pharmacological interaction with sunitinib is abolished by a germ-line mutation (1291T>C) of BCRP/ABCG2 gene

    Cancer Science

    Volume 101, Issue 6, June 2010, Pages: 1493–1500, Haruka Kawahara, Kohji Noguchi, Kazuhiro Katayama, Junko Mitsuhashi and Yoshikazu Sugimoto

    Article first published online : 22 FEB 2010, DOI: 10.1111/j.1349-7006.2010.01539.x

  8. You have free access to this content
    Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation

    BJU International

    Volume 112, Issue 2, July 2013, Pages: E211–E220, Iori Sakai, Hideaki Miyake and Masato Fujisawa

    Article first published online : 10 JAN 2013, DOI: 10.1111/j.1464-410X.2012.11655.x

  9. You have free access to this content
    Management of sunitinib adverse events in renal cell carcinoma patients: The Asian experience

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 2, June 2012, Pages: 132–144, Aiping ZHOU

    Article first published online : 24 APR 2012, DOI: 10.1111/j.1743-7563.2012.01525.x

  10. You have free access to this content
    Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders

    British Journal of Pharmacology

    Volume 171, Issue 24, December 2014, Pages: 5757–5773, Wolf Wrasidlo, Leslie A Crews, Igor F Tsigelny, Emily Stocking, Valentina L Kouznetsova, Diana Price, Amy Paulino, Tania Gonzales, Cassia R Overk, Christina Patrick, Edward Rockenstein and Eliezer Masliah

    Article first published online : 1 DEC 2014, DOI: 10.1111/bph.12875

  11. Sunitinib modulates the radiosensitivity of esophageal squamous cell carcinoma cells in vitro

    Diseases of the Esophagus

    Y.-Q. Ding, H.-C. Zhu, X.-C. Chen, X.-C. Sun, X. Yang, Q. Qin, H. Zhang, Y. Yang, Y.-H. Yang, L. Gao, J.-D. Luo and X.-F. Zhou

    Article first published online : 6 NOV 2015, DOI: 10.1111/dote.12440

  12. You have free access to this content
    Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease

    Arthritis & Rheumatism

    Volume 64, Issue 6, June 2012, Pages: 1990–2000, Niloufar Kavian, Amélie Servettaz, Wioleta Marut, Carole Nicco, Christiane Chéreau, Bernard Weill and Frédéric Batteux

    Article first published online : 25 MAY 2012, DOI: 10.1002/art.34354

  13. You have free access to this content
    Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model


    Volume 55, Issue 1, January 2012, Pages: 141–152, Diego M. Avella, Guangfu Li, Todd D. Schell, Dai Liu, Samuel Shao-Min Zhang, Xi Lou, Arthur Berg, Eric T. Kimchi, Hephzibah Rani S. Tagaram, Qing Yang, Serene Shereef, Luis S. Garcia, Mark Kester, Harriet C. Isom, C. Bart Rountree and Kevin F. Staveley-O'Carroll

    Article first published online : 21 DEC 2011, DOI: 10.1002/hep.24652

  14. Sunitinib–ibuprofen drug interaction affects the pharmacokinetics and tissue distribution of sunitinib to brain, liver, and kidney in male and female mice differently

    Fundamental & Clinical Pharmacology

    Volume 29, Issue 4, August 2015, Pages: 404–416, Christine Li Ling Lau, Sook Tyng Chan, Manimegahlai Selvaratanam, Hui Wen Khoo, Adeline Yi Ling Lim, Pilar Modamio, Eduardo L. Mariño and Ignacio Segarra

    Article first published online : 7 JUN 2015, DOI: 10.1111/fcp.12126

  15. Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function

    The Journal of Clinical Pharmacology

    Volume 50, Issue 4, April 2010, Pages: 472–481, Reza Khosravan, Melvin Toh, May Garrett, JoAnn La Fargue, Grace Ni, Thomas C. Marbury, Suzanne K. Swan, Norman M. Lunde and Carlo L. Bello

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009347868

  16. You have free access to this content
    Sunitinib, a Receptor Tyrosine Kinase Inhibitor, Increases Blood Pressure in Rats without Associated Changes in Cardiac Structure and Function

    Cardiovascular Therapeutics

    Volume 30, Issue 5, October 2012, Pages: 287–294, E. Blasi, J. Heyen, S. Patyna, M. Hemkens, D. Ramirez, A. John-Baptiste, J. Steidl-Nichols and A. McHarg

    Article first published online : 31 MAY 2011, DOI: 10.1111/j.1755-5922.2011.00278.x

  17. You have full text access to this Open Access content
    Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer

    Cancer Science

    Volume 102, Issue 11, November 2011, Pages: 1949–1957, Takeshi Yuasa, Shunji Takahashi, Kiyohiko Hatake, Junji Yonese and Iwao Fukui

    Article first published online : 14 SEP 2011, DOI: 10.1111/j.1349-7006.2011.02054.x

  18. You have free access to this content
    Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes

    BJU International

    Volume 110, Issue 10, November 2012, Pages: 1455–1462, Peter P. Rainer, Bernhard Doleschal, Jonathan A. Kirk, Vidhya Sivakumaran, Zora Saad, Klaus Groschner, Heinrich Maechler, Gerald Hoefler, Thomas Bauernhofer, Hellmut Samonigg, Georg Hutterer, David A. Kass, Burkert Pieske, Dirk von Lewinski and Martin Pichler

    Article first published online : 17 APR 2012, DOI: 10.1111/j.1464-410X.2012.11134.x

  19. Quantitation of sunitinib, an oral multitarget tyrosine kinase inhibitor, and its metabolite in urine samples by nonaqueous capillary electrophoresis time of flight mass spectrometry


    Volume 36, Issue 14, July 2015, Pages: 1580–1587, Juana Rodríguez, Gregorio Castañeda, Lorena Muñoz and Jose C. Villa

    Article first published online : 20 MAY 2015, DOI: 10.1002/elps.201400588

  20. You have free access to this content
    Sunitinib-induced hyperparathyroidism


    Volume 118, Issue 12, 15 June 2012, Pages: 3165–3172, Valentina Baldazzi, Renato Tassi, Alberto Lapini, Alice Lunghi, Eleonora Garofoli, Salvatore Caruso, Marco Carini and Roberto Mazzanti

    Article first published online : 28 SEP 2011, DOI: 10.1002/cncr.26435